+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review

  • ID: 1323075
  • SWOT Analysis
  • June 2016
  • 41 pages
  • GlobalData
1 of 5
Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Navamedic ASA (Navamedic) is a medtech and pharmaceutical products company, which develops, distributes and markets medicines and medical equipment. The company’s Medtech business unit launched a single use, digital urine meter under the brand name Sippi for patients in intensive care. Navamedic's Pharma and Healthcare business is a distributor of products from a number of drug manufacturers. Navamedic has distribution agreement with Aspen pharma, Sequenom Laboratories and Biotech Pharmacon. The company distributes products to hospitals, physicians, pharmacies and health product stores in the Nordic and Benelux regions. The company has operational presence in Sweden, Finland, Denmark, Norway and Iceland. Navamedic is headquartered in Lysaker, Oslo, Norway.

Navamedic ASA Key Recent Developments

May 11, 2016: Navamedic: Q1 2016 Results
Feb 18, 2016: Navamedic announces Strong Sales - Product Launch Affected Profitability
May 26, 2015: Navamedic strengthens product area Female Care
Apr 28, 2015: Navamedic first quarter results 2015
Feb 27, 2015: Navamedic Announces fourth quarter report 2014

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

Loading
LOADING...

3 of 5
List of Tables

List of Figures

Section 1 - About the Company

Navamedic ASA - Key Facts

Navamedic ASA - Key Employees

Navamedic ASA - Key Employee Biographies

Navamedic ASA - Major Products and Services

Navamedic ASA - History

Navamedic ASA - Company Statement

Navamedic ASA - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 - Company Analysis

Navamedic ASA - Business Description

Navamedic ASA - Corporate Strategy

Navamedic ASA - SWOT Analysis

SWOT Analysis - Overview

Navamedic ASA - Strengths

Strength - Business Performance: Consumer Care

Strength - Core Segment: Pharma

Strength - Strategic Partnerships

Navamedic ASA - Weaknesses

Weakness - High Cost Structure

Navamedic ASA - Opportunities

Opportunity - New Product Launches

Opportunity - Acquisition of Observe Medical International AB

Opportunity - New Agreements

Navamedic ASA - Threats

Threat - Intense Competition

Threat - Uncertain R&D Outcomes

Threat - Stringent Government Regulations

Navamedic ASA - Key Competitors

Section 3 - Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Navamedic ASA, Recent Deals Summary

Section 5 - Company’s Recent Developments

May 11, 2016: Navamedic: Q1 2016 Results

Feb 18, 2016: Navamedic announces Strong Sales - Product Launch Affected Profitability

May 26, 2015: Navamedic strengthens product area Female Care

Apr 28, 2015: Navamedic first quarter results 2015

Feb 27, 2015: Navamedic Announces fourth quarter report 2014

Section 6 - Appendix

Methodology

Ratio Definitions

About

Contact Us

Disclaimer

List of Tables

Navamedic ASA, Key Facts

Navamedic ASA, Key Employees

Navamedic ASA, Key Employee Biographies

Navamedic ASA, Major Products and Services

Navamedic ASA, History

Navamedic ASA, Subsidiaries

Navamedic ASA, Key Competitors

Navamedic ASA, Ratios based on current share price

Navamedic ASA, Annual Ratios

Navamedic ASA, Interim Ratios

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Navamedic ASA, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

Navamedic ASA, Performance Chart (2011 - 2015)

Navamedic ASA, Ratio Charts

Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Note: Product cover images may vary from those shown
4 of 5
Weifa ASA
Vingmed AS
Immunocorp Consumer Health
Bluefish Pharma Incentive AB
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll